Molecular Endocrinology, Vol 9, 1455-1460, Copyright © 1995 by Endocrine Society

ARTICLES

A constitutively active mutant thyrotropin-releasing hormone receptor is chronically down-regulated in pituitary cells: evidence using chlordiazepoxide as a negative antagonist

M Heinflink, DR Nussenzveig, H Grimberg, M Lupu-Meiri, Y Oron and MC Gershengorn
Department of Medicine, Cornell University Medical College, New York, New York, USA.

A carboxyl-terminus truncated mutant of the guanine nucleotide-binding (G) protein-coupled TRH receptor (TRH-R) was previously shown to exhibit constitutive, i.e. TRH-independent, activity (C335Stop TRH-R). Chlordiazepoxide (CDE), a known competitive inhibitor of TRH binding to wild-type (WT) TRH-Rs, is shown to compete for binding to C335Stop TRH- Rs also. More importantly, CDE is shown to be a negative antagonist of C335Stop TRH-Rs. CDE rapidly caused the basal rate of inositol phosphate second messenger (IP) formation to decrease in AtT-20 pituitary cells stably expressing C335Stop TRH-Rs (AtT-C335Stop cells), but not in cells expressing WT TRH-Rs (AtT-WT cells). Similar observations were made in HeLa cells transiently expressing C335Stop or WT TRH-Rs. CDE inhibition of IP formation was shown to be specific for TRH-Rs using GH4C1 cells expressing both TRH-Rs and receptors for bombesin. In these cells, CDE inhibited TRH-stimulated IP formation, but had no effect on bombesin-stimulated IP formation. The effects of chronic administration of CDE were studied. Preincubation of AtT- C335Stop cells, but not AtT-WT cells, with CDE for several hours caused an increase in cell surface receptor number (up-regulation) that led to increased TRH stimulation of inositol phosphate formation and elevation of intracellular free Ca2+. Preincubation with CDE did not affect methyl-TRH binding affinity or TRH potency in cells expressing AtT- C335Stop or in AtT-WT cells. We conclude that CDE is a negative antagonist of C335Stop TRH-Rs and that constitutively active C335Stop TRH-Rs are down-regulated in AtT-20 pituitary cells in the absence of agonist.

This article has been cited by other articles:

				B. W. Jones and P. M. Hinkle {beta}-Arrestin Mediates Desensitization and Internalization but Does Not Affect Dephosphorylation of the Thyrotropin-releasing Hormone Receptor J. Biol. Chem., November 18, 2005; 280(46): 38346 - 38354. [Abstract] [Full Text] [PDF]

				D. Du, B. M. Raaka, H. Grimberg, M. Lupu-Meiri, Y. Oron, and M. C. Gershengorn Carboxyl Tail Cysteine Mutants of the Thyrotropin-Releasing Hormone Receptor Type 1 Exhibit Constitutive Signaling: Role of Palmitoylation Mol. Pharmacol., July 1, 2005; 68(1): 204 - 209. [Abstract] [Full Text] [PDF]

				G. Pineyro, M. Azzi, A. deLean, P. W. Schiller, and M. Bouvier Reciprocal Regulation of Agonist and Inverse Agonist Signaling Efficacy upon Short-Term Treatment of the Human {delta}-Opioid Receptor with an Inverse Agonist Mol. Pharmacol., January 1, 2005; 67(1): 336 - 348. [Abstract] [Full Text] [PDF]

				F.-Y. Zeng, A. J. McLean, G. Milligan, M. Lerner, D. T. Chalmers, and D. P. Behan Ligand Specific Up-Regulation of a Renilla reniformis Luciferase-Tagged, Structurally Unstable Muscarinic M3 Chimeric G Protein-Coupled Receptor Mol. Pharmacol., December 1, 2003; 64(6): 1474 - 1484. [Abstract] [Full Text] [PDF]

				S. C. Prinster, N. A. Schulte, M. R. Collins, and M. L. Toews Up-Regulation of {alpha}1B-Adrenergic Receptors with Defects in G Protein Coupling: Ligand-Induced Protection from Receptor Instability Mol. Pharmacol., November 1, 2003; 64(5): 1126 - 1135. [Abstract] [Full Text] [PDF]

				S. Miserey-Lenkei, C. Parnot, S. Bardin, P. Corvol, and E. Clauser Constitutive Internalization of Constitutively Active Angiotensin II AT1A Receptor Mutants Is Blocked by Inverse Agonists J. Biol. Chem., February 15, 2002; 277(8): 5891 - 5901. [Abstract] [Full Text] [PDF]

				J. Li, C. Chen, P. Huang, and L.-Y. Liu-Chen Inverse Agonist Up-Regulates the Constitutively Active D3.49(164)Q Mutant of the Rat {micro}-Opioid Receptor by Stabilizing the Structure and Blocking Constitutive Internalization and Down-Regulation Mol. Pharmacol., November 1, 2001; 60(5): 1064 - 1075. [Abstract] [Full Text]

				G. Pineyro, M. Azzi, A. De Lean, P. Schiller, and M. Bouvier Short-Term Inverse-Agonist Treatment Induces Reciprocal Changes in delta -Opioid Agonist and Inverse-Agonist Binding Capacity Mol. Pharmacol., October 1, 2001; 60(4): 816 - 827. [Abstract] [Full Text] [PDF]

				A. E. Alewijnse, H. Timmerman, E. H. Jacobs, M. J. Smit, E. Roovers, S. Cotecchia, and R. Leurs The Effect of Mutations in the DRY Motif on the Constitutive Activity and Structural Instability of the Histamine H2 Receptor Mol. Pharmacol., May 1, 2000; 57(5): 890 - 898. [Abstract] [Full Text]

				M. Beinborn, S. M. Quinn, and A. S. Kopin Minor Modifications of a Cholecystokinin-B/Gastrin Receptor Non-peptide Antagonist Confer a Broad Spectrum of Functional Properties J. Biol. Chem., June 5, 1998; 273(23): 14146 - 14151. [Abstract] [Full Text] [PDF]

				R. Yu and P. M. Hinkle Signal Transduction, Desensitization, and Recovery of Responses to Thyrotropin-Releasing Hormone after Inhibition of Receptor Internalization Mol. Endocrinol., May 1, 1998; 12(5): 737 - 749. [Abstract] [Full Text]

				H. M. Sadeghi, G. Innamorati, and M. Birnbaumer An X-Linked NDI Mutation Reveals a Requirement for Cell Surface V2R Expression Mol. Endocrinol., June 1, 1997; 11(6): 706 - 713. [Abstract] [Full Text]

				A. Jinsi-Parimoo and M. C. Gershengorn Constitutive Activity of Native Thyrotropin-Releasing Hormone Receptors Revealed Using a Protein Kinase C-Responsive Reporter Gene Endocrinology, April 1, 1997; 138(4): 1471 - 1475. [Abstract] [Full Text] [PDF]

				T. Groblewski, B. Maigret, R. Larguier, C. Lombard, J.-C. Bonnafous, and J. Marie Mutation of Asn111 in the Third Transmembrane Domain of the AT1A Angiotensin II Receptor Induces Its Constitutive Activation J. Biol. Chem., January 17, 1997; 272(3): 1822 - 1826. [Abstract] [Full Text] [PDF]

				M. Lupu-Meiri, R. B. Silver, A. H. Simons, M. C. Gershengorn, and Y. Oron Constitutive Signaling by Kaposi's Sarcoma-associated Herpesvirus G-protein-coupled Receptor Desensitizes Calcium Mobilization by Other Receptors J. Biol. Chem., March 2, 2001; 276(10): 7122 - 7128. [Abstract] [Full Text] [PDF]